&lt;?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://mounjaronews.info/</loc><changefreq>daily</changefreq><priority>1.0</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/"/></url><url><loc>https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/</loc><lastmod>2026-03-01T17:56:41+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T17:56:41+01:00</news:publication_date><news:title>Obésité : remboursement de Mounjaro</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/</loc><lastmod>2026-03-01T17:56:32+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T17:56:32+01:00</news:publication_date><news:title>Mounjaro: Why medical experts say Kenyans should be cautious - Daily Nation</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/</loc><lastmod>2026-03-01T17:56:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T17:56:23+01:00</news:publication_date><news:title>Wegovy vs. Mounjaro: 8 Important Differences</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/</loc><lastmod>2026-03-01T07:54:10+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T07:54:10+01:00</news:publication_date><news:title>Note d’Allurion Technologies relevée suite à l’approbation de la FDA - Investing.com France</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/</loc><lastmod>2026-03-01T07:54:02+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T07:54:02+01:00</news:publication_date><news:title>Que se passe-t-il lorsqu'on arrête les GLP-1 ?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/</loc><lastmod>2026-03-01T07:53:54+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T07:53:54+01:00</news:publication_date><news:title>Mounjaro Eye Side Effects Lawsuit [2026 Update]</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/</loc><lastmod>2026-03-01T00:18:42+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T00:18:42+01:00</news:publication_date><news:title>Mounjaro : la HAS révise à la hausse l’amélioration du service médical rendu dans l’obésité</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/</loc><lastmod>2026-03-01T00:18:34+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T00:18:34+01:00</news:publication_date><news:title>"C'est dramatique" : ce médicament pris par des millions de personnes fait grossir dès qu'on l'arrête - Journal des Femmes Santé</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/</loc><lastmod>2026-03-01T00:18:26+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T00:18:26+01:00</news:publication_date><news:title>Médicament anti-obésité : la Haute autorité de santé donne son feu vert au remboursement de Mounjaro - Le Figaro Santé</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url></urlset>